መነሻ › አልሰራቲቭ ኮላይቲስ › Texas › San Antonio
በSan Antonio፣ TX ለአልሰራቲቭ ኮላይቲስ የሚደረጉ ክሊኒካዊ ጥናቶች
ለአልሰራቲቭ ኮላይቲስ የሚደረጉ 16 ጥናቶች በSan Antonio እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Southern Star Research Institute ( Site 0299), San Antonio
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Southern Star Research Institute /ID# 280822, San Antonio
Confirmatory Clinical Study in Active Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Southern Star Research Institute, San Antonio
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Gastroenterology Research of San Antonio, San Antonio
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 1/2ጤናማ ተሳታዮች ይቀበላሉ
- Xencor Investigative Site, San Antonio
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Site 002, San Antonio
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Southern Star Research Institute, LLC, San Antonio
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Southern Star Research Institute, San Antonio
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Southern Star Research Institute, San Antonio
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Southern Star Research Institute, San Antonio
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
ተሳታዮችን በመፈለግ ላይደረጃ 4
- Gastroenterology Research of San Antonio, LLC, San Antonio
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Southern Star Research Institute, LLC, San Antonio
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Brooke Army Medical center, San Antonio
- Brooke Army Medical center, San Antonio
በሌሎች ከተሞች ለአልሰራቲቭ ኮላይቲስ የሚደረጉ ጥናቶች
- New York City, NY23 ጥናቶች
- Orlando, FL22 ጥናቶች
- Miami, FL21 ጥናቶች
- Houston, TX17 ጥናቶች
- Tacoma, WA15 ጥናቶች
- Chicago, IL15 ጥናቶች
- San Diego, CA15 ጥናቶች
- Tyler, TX14 ጥናቶች
- Colorado Springs, CO14 ጥናቶች
- Los Angeles, CA13 ጥናቶች
- St. Louis, MO13 ጥናቶች
- Washington, DC12 ጥናቶች
በSan Antonio ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር59 ጥናቶች
- የኮሎሬክታል ካንሰር46 ጥናቶች
- የጡንቻ ካንሰር46 ጥናቶች
- Metastatic Cancer44 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)41 ጥናቶች
- ከባድ ሰውነት40 ጥናቶች
- የ2 ዓይነት ስኳረት37 ጥናቶች
- ከመጠን በላይ ክብደት34 ጥናቶች
- የእንቁላል ካንሰር31 ጥናቶች
- የፓንክሪያስ ካንሰር31 ጥናቶች
- የፕሮስቴት ካንሰር28 ጥናቶች
- የኤንዶሜትሪየም ካንሰር27 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።